Lipid‐induced Insulin Resistance Is Associated With Increased Monocyte Expression of Scavenger Receptor CD36 and Internalization of Oxidized LDL
Open Access
- 1 December 2009
- Vol. 17 (12), 2142-2148
- https://doi.org/10.1038/oby.2009.179
Abstract
Elevated free fatty acids (FFAs) contribute to the development of insulin resistance, type 2 diabetes mellitus (T2DM), and may be atherogenic. We tested the relationship among lipid‐induced insulin resistance, endothelial dysfunction, and monocyte capacity to form foam cells through scavenger receptor A (SRA) and CD36. Ten healthy subjects underwent 24‐h infusion of Intralipid/heparin and saline (0.5 ml/min) on two separate occasions followed by brachial artery reactivity testing and a euglycemic hyperinsulinemic (80 mU/(kg·min)) clamp study to determine insulin sensitivity. Isolation of blood monocytes was performed 24 h after infusion. Surface expression and function of CD36 and SRA to take up oxidized low‐density lipoprotein (oxLDL) was determined by flow cytometry and quantitative confocal imaging. Lipid infusion resulted in a twofold increase in serum FFA levels, reduced whole‐body glucose disposal by ∼20% (P < 0.05), and possibly impaired endothelial‐dependent vasodilation (P = 0.1). Blood monocytes obtained during lipid infusion demonstrated a ∼25% increase in cell surface expression of CD36 (P < 0.05) but no change in SRA expression. Enhanced CD36 expression was associated with a 50% increase in internalization of oxLDL (P < 0.05). The increase in CD36 surface expression during lipid infusion correlated inversely with glucose disposal (P < 0.05) and not with FFA levels or brachial artery dilation. These data support a role for FFAs in induction of insulin resistance and provide a link to atherogenic mechanisms mediated by expression of scavenger receptor CD36.Keywords
This publication has 43 references indexed in Scilit:
- Soluble CD36 and Risk Markers of Insulin Resistance and Atherosclerosis Are Elevated in Polycystic Ovary Syndrome and Significantly Reduced During Pioglitazone TreatmentDiabetes Care, 2008
- Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low‐density lipoproteinsProtein Science, 2007
- Effects of Unfractionated Heparin and Glycoprotein IIb/IIIa Antagonists Versus Bivalirdin on Myeloperoxidase Release From NeutrophilsArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemiaAmerican Journal of Physiology-Endocrinology and Metabolism, 2007
- The insulin resistance syndrome: physiological considerationsDiabetes and Vascular Disease Research, 2007
- Identification of the Oxidized Low-Density Lipoprotein Scavenger Receptor CD36 in PlasmaCirculation, 2006
- A CD36-dependent signaling cascade is necessary for macrophage foam cell formationCell Metabolism, 2006
- Stem Cell Transplantation Reveals That Absence of Macrophage CD36 Is Protective Against AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Changes in FAT/CD36, UCP2, UCP3 and GLUT4 gene expression during lipid infusion in rat skeletal and heart muscleInternational Journal of Obesity, 2002
- CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolismJournal of Clinical Investigation, 2001